Studies on protein stability show that freeze-thaw cycles reduce peptide hormone bioavailability by 15-40%, depending on freeze duration and thaw speed
Current clinical guidelines indicate that there is no definitive point at which semaglutide must be discontinued
Glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide receptor agonist Tirzepatide is a once-weekly subcutaneous injectable peptide with agonist activity at both the GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors
Storage in dedicated medication compartments away from food and beverages reduces accidental exposure and contamination risk
Noelker C, Bacher M, Gocke P, Wei X, Klockgether T, Du Y, et al
If you are ready to see whether a personalized plan is right for you, take the free assessment quiz